Predictive Oncology (POAI)

• Market cap: $23.4M
• 1 day: 4.22%
• 5 days: -19.25%
• 1 month: -53.36%
• 3 months: -45.46%
• 6 months: -56.83%
• Year to date: -51.67%
• 1 year: -42.25%
• 5 years: -96.63%
• 10 years: -100%
• Sector: Healthcare
• Industry: Health Information Services

About: Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Employees: 24